Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study
Conclusions
Maitake was well tolerated. Enhanced in vitro neutrophil and monocyte function following treatment demonstrate that Maitake has beneficial immunomodulatory potential in MDS. Further study is warranted.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Allergy & Immunology | Cancer | Cancer & Oncology | Chemistry | Gastroenteritis | Leukemia | Mushrooms | Myelodysplastic Syndrome | Nutrition | Oral Cancer | Study